Transplantation. 2014 Jan 15;97 Suppl 1:S1-S27. doi: 10.1097/01.TP.0000438215.16737.68.
Over the decade between 2003 and 2012, the UK has seen major changes in how organ donation and transplantation is delivered. The number of deceased organ donors has increased from 709 (12.0 per million population [pmp]) to 1,164 (18.3 pmp); this increase has been predominantly a result of an increase in donors after circulatory death (DCD) (from 1.1 pmp to 7.9 pmp) while the numbers of donors after brain death (DBD) has remained broadly stable (around 10.5 pmp). The donor population has become older (from 14% 60 years or over to 35%) and heavier (from 14% with body mass index >=30 kg/m2 to 23%). Despite these changes in demographic factors, the number of organs retrieved from DBD donors has risen from a mean of 3.6 to 4.0 per donor and for DCD donors from 2.2 to 2.6. The number of transplants in adults in 2012 was 2,709 (967 DBD, 708 DCD, and 1,034 living) for kidney alone, 246 pancreas (including 172 kidney and pancreas), 792 (611 DBD, 142 DCD, 36 living, and 3 domino) for liver, 136 for heart only, and 179 (145 DBD and 34 DCD) for lung only. Median waiting times to transplant for adult patients were 1,167, 339, 141, 293, and 311 days, respectively. The proportion of adult non-urgent registrants in 2009 (2007 for kidneys) who were removed from the waiting list or died awaiting a graft within 1 year was 3% for kidneys, 6% for pancreas, 19% for liver, 27% for heart, and 24% for lung. Outcomes after solid organ transplants are improving; for adult patients grafted between 2003 and 2005, 5-year graft survival for kidney is 84% (DBD), 87% (DCD), and 92% (living donor), for simultaneous kidney and pancreas 72%, and for pancreas alone 50% (DBD). Five-year patient survival for liver is 77% (DBD) and 68% (DCD), heart 67%, and lung 52% (DBD). Although rates of organ donation and transplantation have increased in the UK, this has been almost solely because of a rise in DCD donation. Although donor age and weight is increasing, graft survival has generally improved. Despite a recent fall in the number of patients on the transplant waiting list, there remains a significant gap between the need for transplantation and the number of organs available from deceased and living donors. The implementation of a new strategy following the recommendations of the Organ Donation Task Force in 2008 has had a major impact in bringing together clinicians involved in both organ donation and transplantation, and these changes and clinical enthusiasm have been instrumental in achieving success. With an emphasis on the need to increase the family consent rate for organ donation, which has failed to show any improvement over the last 5 years, a new UK strategy for organ donation and transplantation, introduced in 2013, will further increase organ transplantation in the UK.
在 2003 年至 2012 年的十年间,英国在器官捐献和移植的实施方式上发生了重大变化。已故器官捐献者的数量从 709 人(每百万人中有 12.0 人)增加到 1164 人(每百万人中有 18.3 人);这种增长主要是由于死后循环死亡(DCD)的捐献者数量增加(从每百万人中有 1.1 人增加到 7.9 人),而脑死亡(DBD)的捐献者数量基本保持稳定(约 10.5 人)。捐献者群体变得更加老龄化(从 60 岁或以上的 14%增加到 35%)和超重(从身体质量指数≥30 kg/m2的 14%增加到 23%)。尽管人口统计学因素发生了这些变化,但从 DBD 捐献者中获取的器官数量从平均每例 3.6 个增加到 4.0 个,从 DCD 捐献者中获取的器官数量从平均每例 2.2 个增加到 2.6 个。2012 年,成人肾脏单独移植 2709 例(DBD 967 例,DCD 708 例,活体 1034 例),胰腺 246 例(包括 172 例肾胰联合移植),肝脏 792 例(DBD 611 例,DCD 142 例,活体 36 例,多米诺 3 例),心脏 136 例,肺脏 179 例(DBD 145 例,DCD 34 例)。成人患者等待移植的中位数时间分别为 1167、339、141、293 和 311 天。2009 年(2007 年为肾脏)非紧急登记患者中,在 1 年内因等待供体而从等待名单中除名或死亡的比例为 3%(肾脏)、6%(胰腺)、19%(肝脏)、27%(心脏)和 24%(肺脏)。实体器官移植后的结果正在改善;对于 2003 年至 2005 年接受移植的成年患者,肾脏的 5 年移植物存活率为 DBD 84%、DCD 87%和活体捐献者 92%,同时进行肾胰联合移植的存活率为 72%,单独胰腺移植的存活率为 50%(DBD)。肝脏的 5 年患者存活率为 DBD 77%和 DCD 68%,心脏为 67%,肺脏为 52%(DBD)。尽管英国的器官捐献和移植数量有所增加,但这几乎完全是由于 DCD 捐献的增加。尽管捐献者的年龄和体重在增加,但移植物的存活率总体上有所提高。尽管最近移植等待名单上的患者人数有所下降,但在器官捐献者的需求和可用的死者和活体捐献者器官数量之间仍然存在显著差距。2008 年器官捐献工作组提出的新策略的实施对聚集参与器官捐献和移植的临床医生产生了重大影响,这些变化和临床热情在取得成功方面发挥了重要作用。新的英国器官捐献和移植策略强调需要增加家庭对器官捐献的同意率,而过去 5 年来这一比率并没有任何提高,该策略于 2013 年推出,将进一步增加英国的器官移植数量。